Ti Zhang
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 31
- Hepatocellular Carcinoma Treatment and Prognosis 30
-
- RNA modifications and cancer 5
- Co-authors
- Qiang Li (3 shared papers)Yunlong Cui (18 shared papers)Qiang Li (11 shared papers)Huikai Li (18 shared papers)Xiaohong Shen (5 shared papers)Wei Zhang (13 shared papers)Manqing Cao (11 shared papers)Xiaodan He (4 shared papers)
- Journals
- PLoS ONE (7 papers)Journal of Clinical Oncology (4 papers)Frontiers in Oncology (4 papers)BioScience Trends (4 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ti Zhang
135 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 144
- Hepatology 581
- Cancer Research 705
- Oncology 684
- Immunology 379
- Molecular Biology 952
Countries citing papers authored by Ti Zhang
This map shows the geographic impact of Ti Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ti Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ti Zhang more than expected).
Fields of papers citing papers by Ti Zhang
This network shows the impact of papers produced by Ti Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ti Zhang. The network helps show where Ti Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ti Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 179 | |
| 2 | 2016 | 165 | |
| 3 | 2008 | 132 | |
| 4 | 2023 | 98 | |
| 5 | 2016 | 89 | |
| 6 | 2010 | 81 | |
| 7 | 2014 | 75 | |
| 8 | 2019 | 73 | |
| 9 | 2013 | 72 | |
| 10 | 2005 | 71 | |
| 11 | 2013 | 67 | |
| 12 | 2010 | 65 | |
| 13 | 2013 | 60 | |
| 14 | 2016 | 59 | |
| 15 | Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma. | 2012 | 57 |
| 16 | 2020 | 54 | |
| 17 | 2021 | 51 | |
| 18 | 2021 | 49 | |
| 19 | 2017 | 45 | |
| 20 | 2017 | 45 |
About Ti Zhang
Ti Zhang is a scholar working on Hepatology, Molecular Biology, Cancer Research, Oncology and Surgery, having authored 140 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Cancer, Hypoxia, and Metabolism (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer, Lipids, and Metabolism (7 papers), Cancer-related molecular mechanisms research (6 papers), Cancer Mechanisms and Therapy (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Hepatology (581 citations), Cancer Research (705 citations), Oncology (684 citations), Immunology (379 citations) and Molecular Biology (952 citations). Ti Zhang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qiang Li, Yunlong Cui, Qiang Li, Huikai Li, Xiaohong Shen, Wei Zhang, Manqing Cao, Xiaodan He, Hui‐Chuan Sun and Jian Wang. Their work appears in journals such as PLoS ONE, Journal of Clinical Oncology, Frontiers in Oncology, BioScience Trends and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.